Lates News
In the early trading session on Wednesday, shares of Eli Lilly rose by 2%, while shares of Novo Nordisk fell by 3.9%. It is reported that the US government is close to reaching an agreement with Eli Lilly and Novo Nordisk to provide certain obesity medications at prices as low as $149 per month, and to expand limited medical insurance coverage, with final terms yet to be determined.
Latest

